Laguna, A.; MartÃnez-Alonso, B.; Guarnizo-Herrero, V.; Nué-Martinez, J.J.; Dardonville, C.; Torrado-Santiago, S.; Torrado-Salmerón, C.
Development and Characterization of a New Oral Antileishmanial Bis(pyridine-2-Carboxamidine) Drug Through Innovative Dissolution Testing in Biorelevant Media Combined with Pharmacokinetic Studies. Pharmaceutics 2025, 17, 838.
https://doi.org/10.3390/pharmaceutics17070838
AMA Style
Laguna A, MartÃnez-Alonso B, Guarnizo-Herrero V, Nué-Martinez JJ, Dardonville C, Torrado-Santiago S, Torrado-Salmerón C.
Development and Characterization of a New Oral Antileishmanial Bis(pyridine-2-Carboxamidine) Drug Through Innovative Dissolution Testing in Biorelevant Media Combined with Pharmacokinetic Studies. Pharmaceutics. 2025; 17(7):838.
https://doi.org/10.3390/pharmaceutics17070838
Chicago/Turabian Style
Laguna, Almudena, Borja MartÃnez-Alonso, VÃctor Guarnizo-Herrero, J. Jonathan Nué-Martinez, Christophe Dardonville, Santiago Torrado-Santiago, and Carlos Torrado-Salmerón.
2025. "Development and Characterization of a New Oral Antileishmanial Bis(pyridine-2-Carboxamidine) Drug Through Innovative Dissolution Testing in Biorelevant Media Combined with Pharmacokinetic Studies" Pharmaceutics 17, no. 7: 838.
https://doi.org/10.3390/pharmaceutics17070838
APA Style
Laguna, A., MartÃnez-Alonso, B., Guarnizo-Herrero, V., Nué-Martinez, J. J., Dardonville, C., Torrado-Santiago, S., & Torrado-Salmerón, C.
(2025). Development and Characterization of a New Oral Antileishmanial Bis(pyridine-2-Carboxamidine) Drug Through Innovative Dissolution Testing in Biorelevant Media Combined with Pharmacokinetic Studies. Pharmaceutics, 17(7), 838.
https://doi.org/10.3390/pharmaceutics17070838
